Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter

Europace

Volumn 11, Issue 1, 2009, Pages 11-17

  Mont, Lluís ^a   Elosua, Roberto ^b   Brugada, Josep ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Athletes; Atrial fibrillation; Atrial flutter; Endurance sport practice

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLECAINIDE;

ABSTINENCE; AUTONOMIC NERVOUS SYSTEM; BRADYCARDIA; CARDIOVERSION; ENDURANCE SPORT; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART MUSCLE REFRACTORY PERIOD; HUMAN; OCCUPATIONAL DISEASE; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; SUPRAVENTRICULAR PREMATURE BEAT; VAGUS TONE;

ATHLETIC PERFORMANCE; ATRIAL FIBRILLATION; ATRIAL FLUTTER; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; PHYSICAL ENDURANCE; PHYSICAL FITNESS; RISK ASSESSMENT; RISK FACTORS; SPORTS;

EID: 58149098800     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun289     Document Type: Review

References (49)

1. Morris JN, Everitt MG, Pollard R, Chave SP, Semmence AM. Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet 1980;2:1207-10.
2. Kujala UM, Kaprio J, Taimela S, Sarna S. Prevalence of diabetes, hypertension, and ischemic heart disease in former elite athletes. Metabolism 1994;43:1255-60.
3. Blair SN, Kampert JB, Kohl HW 3rd, Barlow CE, Macera CA, Paffenbarger RS Jr et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 1996;276:205-10.
4. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003;107:3109-16.
5. Karjalainen J, Kujala UM, Kaprio J, Sarna S, Viitasalo M. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ 1998;316:1784-5.
6. Mont L, Sambola A, Brugada J, Vacca M, Marrugat J, Elosua R et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J 2002;23:477-82.
7. Elosua R, Arquer A, Mont L, Sambola A, Molina L, Garcia-Moran E et al. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int J Cardiol 2006;108:332-7.
8. Heidbuchel H, Anne W, Willems R, Adriaenssens B, Van de WF, Ector H. Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter. Int J Cardiol 2006;107:67-72.
9. Molina L, Mont L, Marrugat J, Berruezo A, Brugada J, Bruguera J et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace 2008;10:618-23.
10. Mont L, Tamborero D, Elosua R, Molina I, Coll-Vinent B, Sitges M et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace 2008;10:15-20.
11. Taggar JS, Lip GY. Risk predictors for lone atrial fibrillation. Europace 2008;10:6-8.
12. Lampert R. Atrial fibrillation in athletes: toward more effective therapy and better understanding. J Cardiovasc Electrophysiol 2008;19:463-5.
13. Schoonderwoerd BA, Smit MD, Pen L, Van Gelder I. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. Europace 2008;10:668-73.
14. Mozaffarian D, Furberg CD, Psaty BM, Siscovick D. Physical activity and incidence of atrial fibrillation in older adults. The Cardiovascular Health Study. Circulation 2008;118:800-7.
15. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/ AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006;48:854-906.
16. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.
17. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J 1996;131:790-5.
18. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-7.
19. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-11.
20. Leather RA, Kerr CR. Atrial fibrillation in the absence of overt cardiac disease. Atrial fibrillation: Mechanisms and Management. New York, Raven Press; 1992. p93-108.
21. Planas F, Romero-Menor C, Vazquez-Oliva G, Poblet T, Navarro-Lopez F. Natural history of and risk factors for idiopathic atrial fibrillation recurrence (FAP Registry). Rev Esp Cardiol 2006;59:1106-12.
22. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation 1999;99:3028-35.
23. Coumel P. Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur Heart J 1994;15:9-16.
24. Coelho A, Palileo E, Ashley W, Swiryn S, Petropoulos AT, Welch WJ et al. Tachyarrhythmias in young athletes. J Am Coll Cardiol 1986;7:237-43.
25. Furlanello F, Bertoldi A, Dallago M, Galassi A, Fernando F, Biffi A et al. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol 1998;9:S63-8.
26. Masia R, Pena A, Marrugat J, Sala J, Vila J, Pavesi M et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Commun Health 1998;52:707-15.
27. Baldesberger S, Bauersfeld U, Candinas R, Seifert B, Zuber M, Ritter M et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J 2008;29:71-8.
28. Pelliccia A, Maron BJ, Di Paolo FM, Biffi A, Quattrini FM, Pisicchio C et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol 2005;46:690-6.
29. Hoogsteen J, Schep G, Van Hemel NM, Van Der Wall EE. Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up. Europace 2004;6:222-8.
30. Frost L, Frost P, Vestergaard P.Work related physical activity and risk of a hospital discharge diagnosis of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Occup Environ Med 2005;62:49-53.
31. Hanna IR, Heeke B, Bush H, Brosius L, King-Hageman D, Beshai JF et al. The relationship between stature and the prevalence of atrial fibrillation in patients with left ventricular dysfunction. J Am Coll Cardiol 2006;47:1683-8.
32. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
33. Bjornstad H, Storstein L, Meen HD, Hals O. Ambulatory electrocardiographic findings in top athletes, athletic students and control subjects. Cardiology 1994;84:42-50.
34. Biffi A, Maron BJ, Verdile L, Fernando F, Spataro A, Marcello G et al. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2004;44:1053-8.
35. Coumel P. Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur Heart J 1994;15:9-16.
36. Coumel Ph. Neural aspects of paroxysmal atrial fibrillation. In: Falk RG, Podrid PhJ eds, Atrial Fibrillation: Mechanisms and Management. Raven Press; 1992. p109-25.
37. Hoff HE, Geddes LA. Cholinergic factor in auricular fibrillation. J Appl Physiol 1955;8:177-92.
38. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959;58:59-70.
39. Alessi R, Nusynowitz M, Abildskov JA, Moe GK. Nonuniform distribution of vagal effects on the atrial refractory period. Am J Physiol 1958;194:406-10.
40. Swanson DR. Running, esophageal acid reflux, and atrial fibrillation: a chain of events linked by evidence from separate medical literatures. Med Hypotheses 2008;71:178-85.
41. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4.
42. Swanson DR. Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism. Med Hypotheses 2006;66:1085-92.
43. Lindsay MM, Dunn FG. Biochemical evidence of myocardial fibrosis in veteran endurance athletes. Br J Sports Med 2007;41:447-52.
44. Benito B, Gay-Jordi G, Serrano A, Sirenko V, Tamborero D, Berruezo A et al. Chronic exercise induces atrial and right ventricular fibrosis in a rat model. (Abstract Supplement). Eur Heart J 2008;29:740.
45. Sullivan ML, Martinez CM, Gallagher EJ. Atrial fibrillation and anabolic steroids. J Emerg Med 1999;17:851-7.
46. Lau DH, Stiles MK, John B, Shashidhar, Young GD, Sanders P. Atrial fibrillation and anabolic steroid abuse. Int J Cardiol 2007;117:e86-e87.
47. Anne W, Willems R, Van der MN, Van de WF, Ector H, Heidbuchel H. Atrial fibrillation after radiofrequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics. Heart 2004;90:1025-30.
48. Madrid AH, Bueno MG, Rebollo JM, Marin I, Pena G, Bernal E et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002;106:331-6.
49. Furlanello F, Lupo P, Pittalis M, Foresti S, Vitali-Serdoz L, Francia P et al. Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol 2008;19:457-62.